Position in ALVO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$18,450
+$1,300 QoQ
Shares Held
5,000
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 72 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $472,275,691 across 58 Drug Manufacturers - Specialty & Generic names. ALVO ranks #46 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,809,278 | $130,014,715 | |
| 2 | HLN |
Haleon plc
|
4,924,330 | $45,943,997 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
253,026 | $42,644,999 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
74,303 | $40,259,592 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
976,361 | $24,028,242 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
559,389 | $19,394,014 | |
| 7 | VTRS |
Viatris Inc
|
1,175,495 | $18,666,859 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
1,150,820 | $18,447,643 |
All Filings in ALVO
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,450 | 5,000 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $17,150 | 5,000 | Shares | Defined | 2026-05-11 | |
| 2025-09-30 | $52,416 | 6,400 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,648 | 400 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,868 | 400 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $5,292 | 400 | Shares | Defined | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||